Furthermore, integrating immune infiltration analysis and key gene-clinical correlation results, we propose that in gastric cancer, FCRL3 may partially suppress tumor invasion and metastasis by reducing M2 macrophage infiltration, yet overall it still plays a role in promoting cancer progression. Here, FCRL3 is linked to gastric cancer.